DURABILITY OF CLINICAL REMISSION WITH VEDOLIZUMAB IN CROHN’S DISEASE

William Sandborn  1     Silvio Danese  2     Brihad Abhyankar  3     Walter Reinisch  4     Catherine Milch  5    
1 Division Of Gastroenterology, University Of California San Diego, La Jolla, United States
2 Ibd Center, Istituto Clinico Humanitas, Milan, Italy
3 Takeda Global Research & Development Centre (europe) Ltd, London, United Kingdom
4 Department Internal Medicine Iii, Medical University Of Vienna, Vienna, Austria
5 Takeda Pharmaceutica

Conference
UEG Week 2014

Citation
United European Gastroenterology Journal; 2014: 2 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing